πŸ‡ΊπŸ‡Έ FDA
Patent

US 10081669

Therapy for filovirus infection

granted A61KA61K2039/505

Quick answer

US patent 10081669 (Therapy for filovirus infection) held by The United States of America as represented by the Secretary of the Army expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/505